NCT07194304View on ClinicalTrials.gov

Effect of Parenteral Alpha-Tocopherol in the Definitive Surgery of Tetralogy of Fallot

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

January 1, 2024

Study Completion Date

June 1, 2025

Conditions
Tetralogy of Fallot (TOF)Alpha-tocopherolCardiac Surgery
Interventions
DRUG

alpha-Tocopherol

patients in the intervention group received parenteral alpha-tocopherol at a dose of 4 mg/kg body weight

DRUG

Sterile Water for Injection

the control group received a placebo (sterile water for injection/aquabidest)

Trial Locations (1)

Unknown

Cipto Mangunkusumo Hospital, Jakarta

All Listed Sponsors
lead

Dr Cipto Mangunkusumo General Hospital

OTHER